Related Experiment Video

Updated: May 31, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

Acetylation phenotype variation in pediatric patients with atopic dermatitis

Rafi A Majeed Al-Razzuqi1, Ali A Al-Jeboori, Makram M Al-Waiz

  • 1Department of Pharmacology and Therapeutics, College of Medicine, University of Baghdad, Baghdad, Iraq.

Indian Journal of Dermatology
|July 1, 2011
PubMed

Insights

Pediatric patients with atopic dermatitis (AD) who are slow acetylators often experience more severe symptoms and familial allergy history. This suggests a link between N-acetylation phenotype and AD clinical presentation.

Area of Science:

  • Pharmacogenetics
  • Dermatology
  • Allergology

Background:

  • Limited research exists on the connection between acetylator status and allergic diseases.
  • Investigating the role of genetic variations in drug metabolism, specifically N-acetylation, in the context of allergic conditions.

Purpose of the Study:

  • To explore the association between the N-acetylation phenotype in children with atopic dermatitis (AD) and their disease prognosis.
  • To understand if acetylator status influences the severity and clinical manifestation of AD in pediatric patients.

Main Methods:

  • A study involving 36 pediatric patients with AD and 42 healthy controls.
  • Phenotyping participants as slow or rapid acetylators using dapsone and monoacetyldapsone plasma concentrations measured by HPLC.
  • Calculating the acetylation ratio to determine acetylator status.

Main Results:

  • A higher prevalence of slow acetylators was observed in pediatric AD patients (72.2%) compared to controls (69.4%).
  • Slow acetylators with AD frequently had a familial history of allergy (73%).
  • AD severity and specific lesion locations (limbs vs. face/neck) were linked to acetylator status.

Conclusions:

  • The N-acetylation phenotype demonstrates a significant association with clinical aspects of atopic dermatitis in children.
  • Understanding acetylator status may offer insights into personalized approaches for managing pediatric AD.
Abstract

Keywords:
Acetylation phenotypeHanifin-Rajka scoring systematopic dermatitismonoacetyldapsone

More Related Videos

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

Related Concept Videos

Phase II Reactions: Acetylation Reactions01:24

Phase II Reactions: Acetylation Reactions

Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...